Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Seminars in Arthritis and Rheumatism|May 26, 2022
DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective studyMichael Di Iorio, Claire E Cook, Kathleen M M Vanni, et al.
Cell Reports|December 3, 2014
The oncogenic STP axis promotes triple-negative breast cancer via degradation of the REST tumor suppressorKristen L Karlin, Gourish Mondal, Jessica K Hartman, et al.
Nature|September 3, 2015
The spliceosome is a therapeutic vulnerability in MYC-driven cancerTiffany Y-T Hsu, Lukas M Simon, Nicholas J Neill, et al.
The Journal of Clinical Investigation|December 10, 2013
MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosisAtsushi Terunuma, Nagireddy Putluri, Prachi Mishra, et al.
Cell|January 15, 2021
Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancerElizabeth A Bowling, Jarey H Wang, Fade Gong, et al.
Rheumatology (Oxford, England)|September 20, 2022
Obstetric outcomes in women with rheumatic disease and COVID-19 in the context of vaccination statusSinead Maguire, Samar Al-Emadi, Paula Alba, et al.
Pageof 7